Vitamin E deficiency and risk of equine motor neuron disease

被引:38
作者
Mohammed, Hussni O. [1 ]
Divers, Thomas J.
Summers, Brian A.
de lahunta, Alexander
机构
[1] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA
[2] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA
[3] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA
关键词
D O I
10.1186/1751-0147-49-17
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Equine motor neuron disease ( EMND) is a spontaneous neurologic disorder of adult horses which results from the degeneration of motor neurons in the spinal cord and brain stem. Clinical manifestations, pathological findings, and epidemiologic attributes resemble those of human motor neuron disease ( MND). As in MND the etiology of the disease is not known. We evaluated the predisposition role of vitamin E deficiency on the risk of EMND. Methods: Eleven horses at risk of EMND were identified and enrolled in a field trial at different times. The horses were maintained on a diet deficient in vitamin E and monitored periodically for levels of antioxidants - alpha- tocopherols, vitamins A, C, beta- carotene, glutathione peroxidase ( GSH-Px), and erythrocytic superoxide dismutase ( SODI). In addition to the self- control another parallel control group was included. Survival analysis was used to assess the probability of developing EMND past a specific period of time. Results: There was large variability in the levels of vitamins A and C, beta- carotene, GSH- Px, and SODI. Plasma vitamin E levels dropped significantly over time. Ten horses developed EMND within 44 months of enrollment. The median time to develop EMND was 38.5 months. None of the controls developed EMND. Conclusion: The study elucidated the role of vitamin E deficiency on the risk of EMND. Reproducing this disease in a natural animal model for the first time will enable us to carry out studies to test specific hypotheses regarding the mechanism by which the disease occurs.
引用
收藏
页数:9
相关论文
共 50 条
[1]  
Apostolski Slobodan, 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P325
[2]   Environmental risk factors for amyotrophic lateral sclerosis [J].
Armon, C .
NEUROEPIDEMIOLOGY, 2001, 20 (01) :2-6
[3]   EPIDEMIOLOGIC CORRELATES OF SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ARMON, C ;
KURLAND, LT ;
DAUBE, JR ;
OBRIEN, PC .
NEUROLOGY, 1991, 41 (07) :1077-1084
[4]   OXIDATIVE STRESS - ITS ROLE IN THE PATHOGENESIS OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BERGERON, C .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 129 :81-84
[5]   Blood oxidative stress in amyotrophic lateral sclerosis [J].
Bonnefont-Rousselot, D ;
Lacomblez, L ;
Jaudon, MC ;
Lepage, S ;
Salachas, F ;
Bensimon, G ;
Bizard, C ;
Doppler, V ;
Delattre, J ;
Meininger, V .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 178 (01) :57-62
[6]  
BROWNELL B, 1984, J NEUROL NEUROSUR PS, V33, P338
[7]  
BURTIS C, 1994, TXB CLIN CHEM, P1313
[8]  
Cookson MR, 1999, BRAIN PATHOL, V9, P165
[9]   HEREDITARY CANINE SPINAL MUSCULAR-ATROPHY [J].
CORK, LC ;
GRIFFIN, JW ;
MUNNELL, JF ;
LORENZ, MD ;
ADAMS, RJ ;
PRICE, DL .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1979, 38 (03) :209-221
[10]  
CUMMINGS JF, 1990, CORNELL VET, V80, P357